Skip to main content

Table 4 Number of palivizumab doses dispensed by RSV season and eligibility criteria

From: RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study

 

Criterion 1 N = 457

Criterion 2 N = 68

Criterion 3 N = 227

Other N = 50

Total N = 744

n

(%)

n

(%)

n

(%)

n

(%)

n

(%)

First RSV season

366

(80.1)

57

(83.8)

150

(66.1)

36

(72.0)

562

(75.5)

Second RSV season

75

(16.4)

< 10

(< 14.7)

70

(30.8)

< 5

(< 10.0)

147

(19.8)

Third RSV season

16

(3.5)

< 5

(< 7.4)

7

(3.1)

< 15

(< 30.0)

35

(4.7)

  1. *NOTE: (1) Cell sizes of less than 5 have been suppressed
  2. (2) Criterion 1: gestational age < 28 weeks and CLD; criterion 2: gestational age < 28 weeks and identified as Aboriginal; criterion 3: CHD but not in criterion 1 or criterion 2 group
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us